Christina Finnerty, NP
Nurse Practitioner · Idaho Falls, IDNPI 1558430918
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,485 of the $9,982 with a category attached, or 65.0%. Jazz Pharmaceuticals Inc. accounts for 76.5% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $6,566 and has fallen 87.5% since, to $818 in 2025. Among nurse practitioner clinicians in ID with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 168 payments — averaging $59.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$8K
- AbbVie$1K
- Novo Nordisk$146
- Lilly USA, LLC$139
- Axsome Therapeutics, Inc.$108
- Harmony Biosciences LLC$97
- plus $558 from 21 others
What the payments were for
- Consulting fees$8308%
- Speaking & faculty fees$6,48565%
- Food & beverage$2,45225%
- Education$2152%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 21 | $7,636 |
| AbbVie | 84 | $1,299 |
| Novo Nordisk | 8 | $146 |
| Lilly USA, LLC | 10 | $139 |
| Axsome Therapeutics, Inc. | 10 | $108 |
| Harmony Biosciences LLC | 3 | $97 |
| Astellas Pharma US Inc | 4 | $71 |
| Xeris Pharmaceuticals, Inc. | 4 | $69 |
| Boston Scientific | 3 | $51 |
| Daiichi Sankyo Inc. | 3 | $50 |
| Inspire Medical Systems, Inc. | 2 | $47 |
| Galderma Laboratories, L.p. | 1 | $26 |
| Medtronic | 1 | $23 |
| Dexcom, Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Eisai Inc. | 1 | $18 |
| Edwards Lifesciences | 1 | $17 |
| AstraZeneca | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
| Mylan Specialty L.p. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Pfizer | 1 | $15 |
| Viatris Specialty LLC | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Nevro Corp. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,982 in reported general payments places this provider in the 95th percentile of 570 nurse practitioner providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 34 | $680,183 |
| MounjaroTirzepatide | 42 | $55,996 |
| SunosiSolriamfetol Hcl | 41 | $43,978 |
| OzempicSemaglutide | 26 | $29,752 |
| NeuproRotigotine | 11 | $9,326 |
| Modafinil | 25 | $5,305 |
| Levothyroxine Sodium | 66 | $1,641 |
| Buspirone Hcl | 12 | $891 |
| Estradiol | 14 | $702 |
| Doxepin Hcl | 11 | $672 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $656 |
| Ropinirole Hcl | 17 | $646 |
| Bupropion XlBupropion Hcl | 20 | $621 |
| Gabapentin | 34 | $588 |
| Liothyronine Sodium | 15 | $586 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $139 | $55,99642 claims |
| Axsome Therapeutics, Inc.Sunosi | $108 | $43,97841 claims |
| Novo NordiskOzempic | $146 | $29,75226 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 570 nurse practitioner providers in Idaho.
Other nurse practitioner in Idaho Falls
- Amanda ThompsonIdaho Falls$67K
- Deven WillardsonIdaho Falls$10K
- Stephanie LeonardsonIdaho Falls$7K
- Christy TaylorIdaho Falls$6K
- Janet GarlandIdaho Falls$5K
- Rachel PetrusIdaho Falls$5K
- Victoria BlairIdaho Falls$5K
- Kylee JohnsonIdaho Falls$3K
- Brandee SimpsonIdaho Falls$3K
- Kathleen CliffordBoise$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.